SCN10A and Pitt-Hopkins syndrome: Rodent models of PTHS have routinely shown that disruption of Tcf4 function leads to upregulation of Scn10a/Nav1.8 and pharmacological blockade of Nav1.8 is effective at normalizing both physiological and behavioral phenotypes (Fig. 1).